Medical, Health, & Pharmacy News Headlines

Pharmacy News Archives

Medical News Today
EurekAlert!
Univ. of Maryland
Medbroadcast.com
Reuters Health/Medical
New York Times Health
BBC Health & Medical
PRWeb Pharmaceuticals

Popular Medications

Weight Loss & Diet
Pain Relief
Men's Health
Women's Health
Skin Care
Quit Smoking
Sexual Health
Muscle Relaxants
Allergy Relief
Anti-depressants
Anxiety
Sleep Aids
Gastro-intestinal

Insurance & Litigation

Viatical Settlement

Tools & Information

Currency Converter
Resource Directory
Pharmacy Affiliate

 Back to PRWeb Archives



PRWeb: 10-30-2004

Piribo Offers Easy Way to Understand the Chinese Healthcare Markets
Piribo, the online destination for business intelligence for the biopharma industry, has added a range of unique reports covering the healthcare industry in China. [PRWEB Oct 30, 2004]

Buy Prescription Diet Pills and Weight Loss Pills Online from a Trusted Online Pharmacy
Buy prescription diet pills and prescription weight loss pills like Phentermine, Adipex, Didrex, Ionamin, Bontril, Tenuate, Meridia, Xenical and Phendimetrazine online from US-Meds.com. [PRWEB Oct 29, 2004]

MycoLogics, Inc. Further Expands Antifungal Intellectual Property Portfolio
MycoLogics, Inc., an innovative biotechnology company specializing in the development of novel antifungal drugs and therapeutic and prophylactic vaccines, today announced the receipt of patent 6,730,495 and 6,743,598, awarded by the U.S. Patent and Trademark Office, for the discovery of compositions and methods related to both the identification of antimicrobial compounds and for the identification of fungal glucose utilization inhibitors and antifungal agents. [PRWEB Oct 29, 2004]

Soft Gel Technologies, Inc.® Sees Philanthropic Opportunity in Donating Vitamin A Soft Gelatin Capsules to Vitamin Angel Alliance
Soft Gel Technologies has set its sights on helping chldren worldwide in preventing blindness, illness and death with a donation of 1.3 million soft gel capsules of vitamin A to Vitamin Angel Alliance's 'Vitamin See' Campaign. [PRWEB Oct 29, 2004]

Acne, Complexion Problems May be Caused by Microscopic Parasite: Special Soap Works Wonders
Researchers have discovered a tiny, unseen parasite that is believed to be a major cause of acne and other skin problems. A special soap has been successful at killing the parasite and virtually eliminating skin problems. [PRWEB Oct 29, 2004]

When Not to Start a Medical Science Liaison Team
The logic behind the need for a sales force is simple: we have a product, and we need someone to sell it. The logic behind the need for a medical science liaison team is less clear. The symptom of poorly-defined logic for why we need medical liaisons prevails today: medical liaisons are touring the dinner program circuit, medical liaisons are focusing primarily or only on sales support, medical liaisons are taking on the CRA (clinical research associate) role. The fact that medical liaisons can do all these things well - or be trained to do these competently - is what makes creating a liaison team so alluring. I just think these are very expensive and inefficient means to achieve business objectives. [PRWEB Oct 29, 2004]

Research And Markets - Transdermal And Transmucosal Drug Delivery Market Is Thought To Grow Up To $10 Billion By 2010
Research and Markets (researchandmarkets.com/reports/c8112) has announced the addition of Transdermal and Transmucosal Therapeutics - New Developments in Drug Delivery to their offering. [PRWEB Oct 29, 2004]

Research And Markets: October 2004 Meant The Withdrawal Of The Blockbuster Vioxx (Rofecoxib) From The Market.
[PRWEB Oct 29, 2004]

Guide to Viral Clearance-Strategies for Biopharmaceutical Safety
Research and Markets (researchandmarkets.com/reports/c8192) has announced the addition of A Guide to Viral Clearance-Strategies for Biopharmaceutical Safety to their offering. [PRWEB Oct 29, 2004]

Support Staff Development Academy Networking Evening 29 November 20046pm – 8pm - Guest Speaker Actress Jan Harvey 'How to Improve your Presentation Skills'
Are you interested in: -Training, -Continuing Professional Development, -Networking, If the answer is yes, come along to our Network Evening on the 29th November 2004. Book now to get your COMPLIMENTARY place! [PRWEB Oct 29, 2004]

'Senior Lifestyles' to Feature Canada Health Solutions in Segment on Prescription Drug Costs
Canada Health Solutions, headquartered in Richmond, BC, is a provider of innovative healthcare and international prescription fulfillment services. [PRWEB Oct 29, 2004]

Special Report for Contract Research Organizations(CRO) Reveals 10 Ways To Make Beter Hires Faster
A new hardcopy report, published by HireWorks, Inc. CEO Lucia Apollo Shaw, reveals 10 strategies for finding and hiring key employees that are faster, often overlooked by most hiring managers, and will lead to better hiring decisions and profitability for CROs and other life sciences companies. [PRWEB Oct 29, 2004]

MetaClin and Austin Surgical Hospital Announce Collaboration for Clinical Trials
MetaClin Research, Inc. and Austin Surgical Hospital are collaborating to offer patients in the Austin area the opportunity to take part in clinical trials that could greatly improve health care in the future. [PRWEB Oct 28, 2004]

Neuroprotection Market Forecast to Double Within Six Years
The market for products that have a neuroprotective effect will rise to $5.1 billion by 2005 and more than double by 2010 to $11.5 billion, says a new report available from Piribo. [PRWEB Oct 28, 2004]

AllMed Healthcare Peer Review – Doctor, Physician, Nurse, and Hospital Peer Review.
AllMed Healthcare, an Independent Review Organization (IRO), providing doctor, physician, nurse, and hospital peer review services, has released its September 2004 Medical Review News. [PRWEB Oct 27, 2004]

Buy Discount Ativan (Lorazepam) and BuSpar (Buspirone) Online from a Cheap Online Pharmacy
Ativan (Lorazepam) and BuSpar (Buspirone) now available for purchase online at US-Meds.com. [PRWEB Oct 26, 2004]

Generating Pharmaceutical Sales Before Marketing Authorization
When a patient has a serious illness and there is no approved drug available, the physician may want to try one which has not been authorized for marketing by national health authorities but has shown promise in clinical trials.This presents drug-makers with an opportunity to generate revenues while development is still in-progress. [PRWEB Oct 26, 2004]

Research and Markets - More than 110 (Monoclonal Antibody) mAb Products Currently in Clinical Trials and Likely to Play Important Role in Advancement of the Field
Research and Markets has announced the addition of "New Directions in Monoclonal Antibodies: Technologies, Markets, Competition" to their offering. [PRWEB Oct 26, 2004]

Research and Markets - Fluorescent Proteins are Fast Providing Novel Insights into Compound-Induced Responses In Drug Discovery
Research and Markets has announced the addition of Fluorescent Proteins: Technologies, Applications, and Opportunities for Drug Discovery to their offering. [PRWEB Oct 25, 2004]

ClinfoSource and the University of Washington Jointly Launch CME/CNE Accredited Online GCP Course
ClinfoSource and the University of Washington have collaborated in offering a ten module online course providing comprehensive coverage of clinical trial conduct for investigative site personnel. This online course qualifies for a maximum of 6.0 category 1 credits toward the AMA Physician's Recognition Award and a maximum of 7.2 contact hours towards Continuing Education for Nurses and Nurse Practitioners. In addition, ClinfoSource offers online training in other modules for GCP training of biopharmaceutical industry professionals and others in allied areas. [PRWEB Oct 24, 2004]

Nursing Perspective On Hazardous Drug Handling Publishes in the Online Journal of Issues in Nursing
An article by Martha Polovich, MN, RN, AOCNA appears in the September 30, 2004, Online Journal of Issues in Nursing: “Safe Handling of Hazardous Drugs.” Polovich’s article posted to the Online Journal during the same month as an alert from the National Institute for Occupational Safety and Health (NIOSH) on the same subject ("Reducing Occupational Exposure to Antineoplastic and Other Hazardous Drugs in Health Care Settings"). Both the article and the NIOSH Alert examine the issue extensively and provide suggested measures for protecting healthcare workers, including use of a closed-system device for safe handling of antineoplastic and other hazardous drugs. In addition to the recent article, Polovich is profiled online at Expert411.com (click the hazardous drugs tab). [PRWEB Oct 23, 2004]

Bright Prospects for Nitric Oxide Drug Markets
Piribo, the online destination for business intelligence for the biopharma industry, has added a key pharmaceutical intelligence report on the Nitric Oxide market to its collection. [PRWEB Oct 23, 2004]

Marcus Evans Summits Announce Dates for ManuPharma 2005
marcus evans are pleased to announce dates for the annual ManuPharma Europe summit. Following the success of last year’s event, the summit will be held at the Grand Hotel Huis ter Duin in The Netherlands. The event will run from May 16th to 18th 2005 and will bring together senior decision-makers and leading solution provider companies. [PRWEB Oct 23, 2004]

Quick Access to Drug Information Now Available from Piribo.
Piribo, the online destination for business intelligence for the biopharma industry, has added another key pharmaceuticals industry reference manual to its collection. [PRWEB Oct 22, 2004]

Recent Growth Increases Size Of The Specialty Pharmaceutical Market To Approximately $22 Billion.
Research and Markets has announced the addition of Specialty Pharmacies Market Overview to their offering. [PRWEB Oct 22, 2004]

Research And Markets - Arsenal Of Antifungal Agents Need To Be Employed To Address Fungal Infections
Research and Markets has announced the addition of Antifungals: 2004 and Beyond to their offering. [PRWEB Oct 22, 2004]

PharmaDirections, Inc. President Richard Soltero Selected to Present at 2004 ISPE Annual Meeting
Dr. Soltero to address Risk Based Manufacturing as part of a series of educational and training presentations for the International Society for Pharmaceutical Engineering (ISPE) Annual Meeting in October 2004 [PRWEB Oct 22, 2004]

The Lifestyle Drugs Market Is Currently Worth A Phenomenal $23bn
Research and Markets has announced the addition of 'The Lifestyle Drugs Outlook to 2008: Unlocking new value in well-being' to their offering. [PRWEB Oct 22, 2004]

Orthopedic Surgeon Blasts Vioxx® and COX-2 Inhibitors
MD says, “I lost a parent to Vioxx®.” [PRWEB Oct 21, 2004]

Medical Doctor Warns of 16,000 Annual Deaths from Anti-Inflammatory Drugs
Suggests Topicals instead of Advil® or Ibuprofen. [PRWEB Oct 21, 2004]

© PR Web: Medical Pharmaceuticals